ISPD Board of Directors




Editor in Chief, Prenatal Diagnosis

Lyn Chitty, PhD, MRCOG
London, UK


Mahesh Arjandas Choolani, MD, PhD


Rossa Chiu, MBBS, PhD, FRCPA
Sha Tin, Hong Kong


Lee Shulman, MD*
Northbrook, Illinois, USA

Past President

Louise E. Wilkins-Haug, MD, PhD
Boston, Massachusetts, USA





April Adams, MD*
Houston, Texas, USA
Early Career Director


Lisa Hui, MBBS, PhD*
Heidelberg, Australia


Maria Laura Igarzabal, MD
Buenos Aires, Argentina


Brynn Levy, M.Sc.(Med), PhD*
New York, New York, USA


Mark Pertile, PhD*
Melbourne, Australia


Tim Van Mieghem*, MD, PhD
Toronto, Canada


Neeta Lakshmi Vora, MD
Chapel Hill, North Carolina, USA


Conflict of Interest

ISPD is committed to full transparency regarding its leadership and the potential for conflicts of interest. Each member of the Board of Directors is required annually to review the Conflict of Interest Policy and disclose, in writing, any potential conflicts. As noted in the policy, if a Director has a conflict of interest relating to any matter under consideration for a decision by the Board of Directors, he or she shall abstain from any vote, discussion (except as the remaining Board deems necessary for informational purposes), or any attempt to influence the decision of the Board on that matter. The Board may also require the Director to be excused from a meeting while the matter is being deliberated and voted. Relevant financial or other relationships exist between the following ISPD Board members and the commercial interests listed below:
Rossa W. Chiu, MBBS, PhD, FRCPA
Founder of Xcelom, Cirina and DRA; Equity in GRAIL and DRA; Consultant for GRAIL; Expert panelist of Illumina; Research funding from GRAIL; Patent royalty income from Illumina, Sequenom, Xcelom, GRAIL and DRA
7 March 2018

Neeta Lakshmi Vora, MD
I declare no conflict of interest.
20 August 2018

Louise E. Wilkins-Haug, MD, PhD
Genetics Section Editor
2 May 2017